Who Paid My Doc
Wenhua Chen
Pediatric Otolaryngology Indianapolis, IN Medical Doctor
NPI 1952795890 CMS profile 8302085
720 Eskenazi Ave, Indianapolis, IN 46202
General payments
$360
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Wenhua Chen of Indianapolis, IN is reported in the CMS Open Payments database as having received $360 across 7 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 45th percentile of Pediatric Otolaryngology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $156 | 2 | |
| 2024 | General | $16 | 1 | |
| 2023 | General | $169 | 3 | |
| 2020 | General | $19 | 1 |
Beside peers
- Wenhua Chen
- Pediatric Otolaryngology median
- Middle half of Pediatric Otolaryngology
- National median
In program year 2025, general payments to Wenhua Chen were reported at $156. Among 368 Pediatric Otolaryngology profiles paid that year, the median was $172 and the middle half received between $78 and $412.
Show as a table
| Year | Wenhua Chen | Pediatric Otolaryngology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $127 | $51–$271 | $163 |
| 2020 | $19 | $64 | $31–$165 | $114 |
| 2021 | $0 | $88 | $26–$225 | $132 |
| 2022 | $0 | $122 | $43–$316 | $149 |
| 2023 | $169 | $128 | $52–$340 | $160 |
| 2024 | $16 | $150 | $65–$384 | $164 |
| 2025 | $156 | $172 | $78–$412 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 21 billing codesPaid by Medicare
$5,752
Medicare patients
13
Services billed
29
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Atrial fibrillation | 0% | |
| Osteoporosis | 0% | |
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
7 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Otolaryngology in Indiana
Stacey Ishman
Pediatric Otolaryngology · Indianapolis, IN
Matthew Partain
Pediatric Otolaryngology · Indianapolis, IN
Bruce Matt
Pediatric Otolaryngology · Indianapolis, IN
Richard Miyamoto
Pediatric Otolaryngology · Indianapolis, IN
Ravindhra Elluru
Pediatric Otolaryngology · Indianapolis, IN
Matthew Provenzano
Pediatric Otolaryngology · Michigan City, IN
Related records
Pediatric Otolaryngology in Indiana
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Otolaryngology
Everyone recorded under this specialty, nationwide.
Doctors in Indiana
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.